EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KIAA1429 increases FOXM1 expression through YTHDF1–mediated m6A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma

Yue Wu, Yi Luo, Xingchen Yao, Xiangjun Shi, Ziyu Xu, Jie Re, Ming Shi, Meng Li, Junpeng Liu, Youzhi He, Xinru Du

Cell Biology and Toxicology · 26.07.2024 · 40 (1)

DOI: 10.1007/s10565-024-09904-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biology and Toxicology, online erschienen am 26.07.2024. Verfasst von Yue Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Beijing Chao-Yang Hospital, No.8 Gongti South Rd, Chaoyang District, Beijing, 100020, China. Hauptthemen laut MEDLINE: Glycolysis, Forkhead Box Protein M1, Multiple Myeloma, RNA-Binding Proteins. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Multiple myeloma (MM) is a deadly plasma cell malignancy with elusive pathogenesis. N6-methyladenosine (m6A) is critically engaged in hematological malignancies. The function of KIAA1429, the largest component of methyltransferases, is unknown. This study delved into the mechanism of KIAA1429 in MM, hoping to offer novel targets for MM therapy.

Methods

Bone marrow samples were attained from 55 MM patients and 15 controls. KIAA1429, YTHDF1, and FOXM1 mRNA levels were detected and their correlation was analyzed. Cell viability, proliferation, cell cycle, and apoptosis were testified. Glycolysis-enhancing genes (HK2, ENO1, and LDHA), lactate production, and glucose uptake were evaluated. The interaction between FOXM1 mRNA and YTHDF1, m6A-modified FOXM1 level, and FOXM1 stability were assayed. A transplantation tumor model was built to confirm the mechanism of KIAA1429.

Results

KIAA1429 was at high levels in MM patients and MM cells and linked to poor prognoses. KIAA1429 knockdown restrained MM cell viability, and proliferation, arrested G0/G1 phase, and increased apoptosis. KIAA1429 mRNA in plasma cells from MM patients was positively linked with to glycolysis-enhancing genes. The levels of glycolysis-enhancing genes, glucose uptake, and lactate production were repressed after KIAA1429 knockdown, along with reduced FOXM1 levels and stability. YTHDF1 recognized KIAA1429-methylated FOXM1 mRNA and raised FOXM1 stability. Knockdown of YTHDF1 curbed aerobic glycolysis and malignant behaviors in MM cells, which was nullified by FOXM1 overexpression. KIAA1429 knockdown also inhibited tumor growth in animal experiments.

Conclusion

KIAA1429 knockdown reduces FOXM1 expression through YTHDF1-mediated m6A modification, thus inhibiting MM aerobic glycolysis and tumorigenesis. Graphical Abstract KIAA1429 knockdown reduces FOXM1 expression through YTHDF1-mediated m6A modification, thus inhibiting aerobic glycolysis and tumorigenesis in MM

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycolysisForkhead Box Protein M1Multiple MyelomaRNA-Binding ProteinsCell ProliferationCarcinogenesisHumansCell Line, TumorAnimalsMaleFemaleMiceAdenosineApoptosisGene Expression Regulation, NeoplasticMiddle AgedMice, NudeMice, Inbred BALB C

Stichwörter der Autor:innen

Aerobic glycolysisFOXM1KIAA1429Multiple myelomaYTHDF1m6A

Substanzen

Forkhead Box Protein M1RNA-Binding ProteinsFOXM1 protein, humanYTHDF1 protein, humanN-methyladenosineAdenosineVIRMA protein, human

Autor:innen und Institutionen

  • Department of Orthopedics, Beijing Chao-Yang Hospital, No.8 Gongti South Rd, Chaoyang District, Beijing, 100020, China.
  • Department of Spine Surgery, Hengyang Medical School, The Affiliated Changsha Central Hospital, University of South China, Changsha, 410007, Hunan, China.
  • Department of Orthopedics, Beijing Chao-Yang Hospital, No.8 Gongti South Rd, Chaoyang District, Beijing, 100020, China. duxinru@ccmu.edu.cn.

Zitieren

APA

Wu, Y., Luo, Y., Yao, X., Shi, X., Xu, Z., Re, J., Shi, M., Li, M., Liu, J., He, Y., & Du, X. (2024). KIAA1429 increases FOXM1 expression through YTHDF1–mediated m6A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma. Cell Biology and Toxicology, 40(1). https://doi.org/10.1007/s10565-024-09904-2

Vancouver

Wu Y, Luo Y, Yao X, Shi X, Xu Z, Re J, et al. KIAA1429 increases FOXM1 expression through YTHDF1–mediated m6A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma. Cell Biology and Toxicology. 2024;40(1). doi:10.1007/s10565-024-09904-2

BibTeX
@article{Wu2024,
  author = {Wu, Yue and Luo, Yi and Yao, Xingchen and Shi, Xiangjun and Xu, Ziyu and Re, Jie and Shi, Ming and Li, Meng and Liu, Junpeng and He, Youzhi and Du, Xinru},
  title = {KIAA1429 increases FOXM1 expression through YTHDF1–mediated m6A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma},
  journal = {Cell Biology and Toxicology},
  year = {2024},
  volume = {40},
  number = {1},
  doi = {10.1007/s10565-024-09904-2}
}
Kostenlos starten →